Cargando…

Prognostic factors of IgA nephropathy presenting with mild proteinuria at the time of diagnosis (a multicenter cohort study)

BACKGROUND: Clinical factors affecting renal prognosis in patients with immunoglobulin A nephropathy (IgAN) and low urinary protein excretion (U-Prot) remain unclear. This study evaluated such factors in patients with clinical grade I (CG-I) IgAN with U-Prot < 0.5 g/day. METHODS: This secondary a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirai, Sayuri, Yasuda, Takashi, Kumagai, Hiroo, Matsunobu, Hanako, Ichikawa, Daisuke, Shibagaki, Yugo, Yasuda, Yoshinari, Matsuzaki, Keiichi, Hirano, Keita, Kawamura, Tetsuya, Suzuki, Yusuke, Maruyama, Shoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023643/ https://www.ncbi.nlm.nih.gov/pubmed/36705811 http://dx.doi.org/10.1007/s10157-023-02316-2

Ejemplares similares

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Long-term prognosis of IgA nephropathy presenting with minimal or no proteinuria: A single center experience
por: Imai, N., et al.
Publicado: (2016)

Association Between Tonsillectomy and Outcomes in Patients With Immunoglobulin A Nephropathy
por: Hirano, Keita, et al.
Publicado: (2019)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy
por: Sato, Hirotaka, et al.
Publicado: (2021)

Associations of corticosteroid therapy and tonsillectomy with kidney survival in a multicenter prospective study for IgA nephropathy
por: Kawamura, Tetsuya, et al.
Publicado: (2023)

Adult orthostatic proteinuria
por: Uehara, Keita, et al.
Publicado: (2014)

The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy
por: Hirano, Keita, et al.
Publicado: (2012)

Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients
por: Kaihan, Ahmad Baseer, et al.
Publicado: (2019)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity
por: Okonogi, Hideo, et al.
Publicado: (2018)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Abrupt worsening of occult IgA nephropathy after the first dose of SARS-CoV-2 vaccination
por: Fujita, Yoko, et al.
Publicado: (2022)

Nationwide survey on current treatments for IgA nephropathy in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2013)

Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy
por: Suzuki, Tomo, et al.
Publicado: (2020)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia
por: Shirai, Sayuri, et al.
Publicado: (2019)

Canagliflozin Markedly Decreased Proteinuria in a Patient With IgA Nephropathy
por: Aameish, Muhammad, et al.
Publicado: (2021)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
por: Okonogi, Hideo, et al.
Publicado: (2012)

Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Goswami, R. P., et al.
Publicado: (2013)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
por: Sarcina, Cristina, et al.
Publicado: (2016)

Severity of foot process effacement is associated with proteinuria in patients with IgA nephropathy
por: Lee, Ji-Hye, et al.
Publicado: (2020)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

Evidence-based clinical practice guidelines for IgA nephropathy 2014
por: Yuzawa, Yukio, et al.
Publicado: (2016)

Comment on: Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Nasri, H.
Publicado: (2014)

Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria
por: Komatsu, Hiroyuki, et al.
Publicado: (2015)

Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis
por: Zhang, Jialing, et al.
Publicado: (2021)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

Clinical and immunological implications of increase in CD208(+) dendritic cells in tonsils of patients with immunoglobulin A nephropathy*
por: Takechi, Hanako, et al.
Publicado: (2013)

Author response on: Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Goswami, R. P., et al.
Publicado: (2014)

Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria
por: Ruan, Yiping, et al.
Publicado: (2015)

Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria
por: Pei, Gaiqin, et al.
Publicado: (2020)

Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria
por: Barratt, Jonathan, et al.
Publicado: (2022)

Tonsillectomy Monotherapy for IgA Nephropathy: A Case Series
por: Marumoto, Hirokazu, et al.
Publicado: (2020)

Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification
por: Hirano, Keita, et al.
Publicado: (2015)

Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis
por: Liu, Yanli, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qpuu5isoc73pliaj5leha0212t